A

Araris Biotech AG

24 employees

Araris Biotech is a biotechnology platform enables the attachment of any payload to ‘off the shelf’ antibodies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Antibody Drug Conjugates and ADCs

Date founded

2019

Funding rounds raised

Total raised

$24M

from 16 investors over 16 rounds

A

Araris Biotech AG raised undisclosed on April 28, 2023

Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung

A

Araris Biotech AG raised $24M on October 4, 2022

Investors: Pureos Bioventures, Schroders Capital, b-to-v Partners AG, VI Partners AG and Redalpine

A

Araris Biotech AG raised $17M on October 22, 2020

Investors: Pureos Bioventures, Kinled Holding Ltd, Redalpine, b-to-v Partners AG and VI Partners AG

A

Araris Biotech AG raised $2.5M on August 20, 2019

Investors: VI Partners AG and Redalpine

A

Araris Biotech AG raised $101K on June 12, 2019

Investors: Venture Kick

A

Araris Biotech AG raised $20K on June 1, 2019

Investors: Venture Kick

A

Araris Biotech AG raised $10K on July 10, 2018

Investors: Venture Kick

FAQ